Health
Gene Editing Trial Raises Safety Concerns in China
A second child's death in a gene editing trial in China has rekindled debate on clinical trial transparency and safety. Critics argue for stricter regulations to prevent future tragedies.
Coverage timeline — 1 article
STAT News
With a second delayed report of a child's death in China, criticism is rising of a looser form of clinical trial. One expert: what "bothers me is the lack of…
2026-08-05 17:46 UTC